Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperthermia and CCRT for Recurrent Head and Neck Cancer
NCT02567383Phase 2Unknown
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Sep 2015
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in head and neck cancer (HNC), sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Primary endpoint: Tumor Response Rate at 12 weeks. Status: unknown.
02
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02567383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567383.